Memo RE: Albertsons Opioid Settlement
Extracted text (via pymupdf_layout)
12290 characters
Justin S. Pierce 17851 North 85th Street, Suite 175 Rodney F. W. States Stephen B. Coleman Scottsdale, Arizona 85255 Amy B. Chan Trish Stuhan Jessica D. Silva Christina Estes-Werther 2812 North Norwalk, Suite 107 Matthew P. Podracky Jon M. Paladini Mesa, Arizona 85215 Justin B. Petersen Joseph D. Estes Michelle N. Stinson Dominic L. Verstegen Alexandra N. Cayton Allen H. Quist Matthew W. Schiumo Reilly K. Cunnington Kate Cox Katelynn C. Marmolejo MEMORANDUM To: Mayor and Council, City of El Mirage Cc: Crystal Dyches, City Manager Justin S. Pierce, City Attorney From: Christina Estes-Werther, Pierce Coleman PLLC Re: Summary of Albertsons Opioid Settlement Terms and Subdivision Settlement Participation Form Date: October 26, 2026 The purpose of this Memo is to provide an overview of the settlement terms for the new Albertsons Settlement and outline next steps for the City of El Mirage (the “City”) if it seeks to participate in the Albertsons Settlement. The full settlement documents for Albertsons are on file with the Clerk. Background Since 2021, as part of the One Arizona Distribution of Opioid Settlement Funds Agreement (“One Arizona Funds Agreement”)1, the State of Arizona and the City have participated in national opioid settlements as follows: • J&J and Distributors McKesson, Cardinal Health, and AmerisourceBergen (“2021 National Settlements”); • Teva, Allergan, Walmart, Walgreens and CVS (“2022 National Settlements”); and • Kroger (“Kroger Settlement”). • Purdue/Sackler Settlement (“Purdue Settlement”). • Alvogen, Inc., Amneal Pharmaceuticals LLC, Apotex Corp., Hikma Pharmaceuticals USA Inc., Indivior Inc, Viatris, Inc., Sun Pharmaceuticals Industries, Inc., and Zydus Pharmaceuticals (USA) Inc. (“Secondary Manufacturers”). 1 For the full One Arizona Funds Agreement, visit https://www.one-arizona.com/ ATTORNEY CONTACT: Tel.: 602-772-5506 Christina Estes-Werther Fax: 877-772-1025 Direct Line: 602-772-5524 Website: www.piercecoleman.com Email: Christina@PierceColeman.com Mayor and Council, City of El Mirage October 27, 2026 Page 2 Municipal Participation in the Settlement A Notice was sent by email from opioidsparticipation@rubris.com to the City on October 21, 2026 providing notice of the Albertsons Settlement Agreements (“Settlement Agreement”) and the deadline for becoming an Initial Participating Subdivision. In order to participate in the settlement proceeds, the City must execute and submit a Subdivision Settlement Combined Participation Form (“Participation Form”) before December 30, 2026 for the City to be considered an “Initial Participating Subdivision.” If for any reason the Settlement Agreement does not become effective, the Participation Form is void.2 By executing and returning a Participation Form: 1. The City is aware of and has reviewed and understands the terms of the Participation Form; 2. The City agrees to dismiss with prejudice any Released Claims against each of the Albertsons; 3. The City agrees that for the matter In re National Prescription Opiate Litigation, MDL No. 2804, Plaintiff’s Executive Committee may execute and file on behalf of the Town a Stipulation of Dismissal with Prejudice substantially in the form online at https://nationalopioidsettlement.com/wp- content/uploads/2025/08/Master-Template-Stipulation-of-Dismissal-8-manufacturer.pdf; 4. The City agrees to the terms of the applicable settlement agreement pertaining to Participating Subdivisions; 5. The City is entitled to the benefits of the Settlement Agreements; 6. The City agrees to use monies it receives as required under the Settlement Agreements; 7. The City submits to the jurisdiction of the court to resolve disputes relating to the Settlement Agreements; 8. The City has the right to enforce the Settlement Agreements; 9. The City provides a release of claims to the fullest extent of its authority for each of the Albertsons; 10. The City takes on all rights and obligations of a Participating Subdivision as set forth in the Settlement Agreements; and 11. The City agrees that if the Participation and Release Form is interpreted differently from the Settlement Agreement, the Agreement controls. The primary provision for the City to consider is the release of all claims against Albertsons in exchange for settlement monies. The release language is as follows: As of the Effective Date, the Released Entities are hereby released and forever discharged from all of the Releasors’ Released Claims. Each Settling State (for itself and its Releasors) and Participating Subdivisions hereby absolutely, unconditionally, and irrevocably covenants not to bring, file, or claim, or to cause, assist or permit to be brought, filed, or claimed, or to otherwise seek to establish liability for any Released Claims against any Released Entity in any forum whatsoever. The releases provided for in this Agreement are intended by the Parties to be broad and shall be interpreted so as to give the Released Entities the broadest possible bar against any liability relating in any way to Released 2 Section IV Settlement Payments; Section X. Release. Mayor and Council, City of El Mirage October 27, 2026 Page 3 Claims and extend to the full extent of the power of each Settling State and its Attorney General to release claims. This Agreement shall be a complete bar to any Released Claim.3 Additional requirements include that the City will not seek to recover for amounts paid under this Agreement based on indemnification, contribution, or any other theory from a manufacturer, pharmacy, hospital, pharmacy benefit manager, health insurer, third-party vendor, trade association, distributor, or health care practitioner; provided that a Released Entity shall be relieved of this prohibition with respect to any entity that asserts a Claim-Over against it. For the avoidance of doubt, nothing herein shall prohibit the City from recovering amounts owed pursuant to insurance contracts; a general release under § 1542 of the California Civil Code, which encompasses claims not known or suspected to exist; and that the City does not waive, release or limit any criminal liability, workers’ compensation claims, claims for liability under tax or securities laws, claims against parties who are not Released Entities or private individuals and any claims arising under this Agreement for enforcement of this Agreement. Further, the Parties agree to the entry of injunctive terms, which requires Albertsons to implement or maintain a Controlled Substance Compliance Program.4 Timeline Following Participation Form Submission Following the deadline for subdivision participation, the State of Arizona and the other Settling States shall notify Albertsons and the Enforcement Committee of their decision and within thirty (30) days after the Initial Participation Date (“Reference Date”), Albertsons must inform the Settling States of whether conditions are satisfied and if there are sufficient eligible states and subdivisions to proceed with the settlement.5 If the settlements move forward, the Parties will file the Consent Judgments and Participation Forms, which are effective as of the Reference Date. If the settlement does not proceed, the Settlement Agreements and releases shall be void.6 The Settlement Agreement is terminated if the Consent Judgment is not timely entered within one hundred eighty (180) days or is not approved by the court unless an extension is granted.7 Distribution and Use of Settlement Funds The amount to be distributed to Arizona under the Settlement Agreements is currently unknown and depends on the level of participation by eligible states and subdivisions. The Settlement Agreements require a Settlement Fund to be established and Albertsons shall make annual payments over a period of years to the Fund.8 Distribution of funds is based on population figures published by the U.S. Census Bureau’s population estimates for July 1, 2019, released May 2020.9 Settlement funds will be disbursed to Settling States and Participating Subdivisions unless otherwise permitted in the Agreement (Exhibit G) and subject to additional reporting requirements. 3 Section X. Release. 4 Exhibit P - Pharmacy Controlled Substance Compliance Program & Anti-Diversion Injunctive Terms. 5 Section II. Participation by Eligible States and Condition to Preliminary Agreement. 6 Section VIII Condition to Effectiveness of Agreement and Filing of Consent Judgment, (C) Notice by Albertsons. 7 Section XIII. Miscellaneous, (W) Termination. 8 Section V. Allocation and Use of Settlement Payments. 9 Section XIII. Miscellaneous, (A) Population of General Purpose Governments. Mayor and Council, City of El Mirage October 27, 2026 Page 4 Similar to the previous settlement, the settlement funds must be used in connection with future opioid-remediation efforts including care, treatment and other programs and expenditures designed to address the misuse and abuse of opioid products; treat or mitigate opioid use or related disorders; or mitigate other alleged effects of the opioid epidemic. See Exhibit E. Reporting Requirements Each settlement requires reporting to demonstrate that the settlement funds are allocated to opioid- remediation efforts or any other lawful purpose.10 See Subsection F. Compliance Reporting and Accountability in the One Arizona Funds Agreement. The City does not have to report if its monies are allocated to the county for opioid remediation. More information will be provided once the Settlement Agreements are in effect, settlement amount is known, and distribution is confirmed to the State of Arizona. Next Steps 1. Place an action item on the agenda prior to December 30, 2026 for Council to decide if the City will participate in the Settlement Agreement. The full settlement documents are on file with the Clerk. 2. If the Council approves opting in to the Settlement Agreement, the City’s designated point of contact will submit the Participation Form by December 30, 2026. The Participation Form, can be signed by one of three methods: a. Electronic Signature via DocuSign; b. Manual Signature returned via DocuSign; or c. Manual Signature returned via electronic mail. For assistance with the DocuSign, contact Rubris at opioidsparticipation@rubris.com or Jane Fallon at Jane.Fallon@azag.gov at the Attorney General’s Office. 3. Once the settlement is finalized, the release against Albertsons will be in effect and Rubris and the Attorney General’s Office will provide additional information about the distribution formula and reporting requirements. 10 Section V. Allocation and Use of Settlement Payments, (B) Use of Settlement Payments. Mayor and Council, City of El Mirage October 27, 2026 Page 5 ATTACHMENT A The following settlement documents and exhibits are on file with the Clerk: 1. Albertsons Settlement Agreement (dated August 20, 2026) a. Exhibit A – Alleged Harms b. Exhibit B – Enforcement Committee Organization Bylaws c. Exhibit C – Litigating Subdivisions d. Exhibit D – [Intentionally Omitted] e. Exhibit E – List of Opioid Remediation Uses f. Exhibit F – List of Eligible States and Overall Allocation Percentages g. Exhibit G – List of Subdivisions and Allocation Percentages h. Exhibit H – [Intentionally Omitted] i. Exhibit I – Primary Subdivisions and Subdivisions with Population Over 10,000 j. Exhibit J – Albertsons' Subsidiaries, Affiliates, and Joint Ventures (Released Entities) k. Exhibit K – Subdivision Participation and Release Form l. Exhibit L – Settlement Fund Administrator Terms (to be inserted prior to the Effective Date) m. Exhibit M – Payments Schedule n. Exhibit N – Additional Remediation Amount Allocation Percentages o. Exhibit O – Adoption of a State Subdivision Agreement p. Exhibit P – Pharmacy Controlled Substance Compliance Program & Anti-Diversion Injunctive Terms q. Exhibit Q – [Intentionally Omitted] r. Exhibit R – Agreement on Attorneys’ Fees, Costs, and Expenses s. Exhibit S – [Intentionally Omitted] t. Exhibit T – [Intentionally Omitted] u. Exhibit U – Exemplar Tax Form v. Exhibit V – [Intentionally Omitted] w. Exhibit W – Non-Litigating Threshold Subdivisions (to be inserted prior to the Effective Date) x. Exhibit X – Governor’s Release of Opioid-Related Claims Pursuant to the Albertsons Settlement Agreement